PRODUCTS & INNOVATION
WITH BURSTDR STIMULATION, TAKE CONTROL OF YOUR PAIN
Saving energy and battery life without compromising pain relief.
Aug 28 2020
Sometimes the biggest innovations don't come as bright and shiny new inventions. Instead, they're found in incremental improvements.
That's the case with new research around Abbott's BurstDR™ stimulation therapy for chronic pain management. The system, which delivers electrical pulses to neutralize pain signals, isn't new. What is new is the revelation that the voltage can be tempered to save energy and battery life — without compromising pain relief.
A Life Less Interrupted
In a multicenter study of BurstDR spinal cord stimulation, 100% of participants on a low-energy programming settings felt full pain relief on less than six hours of battery use per day, and 43% of participants achieved pain relief on less than 2 hours of battery use per day.
By understanding how the brain naturally manages pain, doctors created BurstDR stimulation to mimic natural patterns found in the brain.1 It works by using mild electrical pulses to change pain signals as they travel from the spinal cord to the brain,2 and BurstDR stimulation has been proven to provide effective pain relief in low doses.1
The result: With the Proclaim XR SCS system, you can have hassle-free pain relief with a battery that lasts up to 10 years at low-dose settings* without ever needing to charge the system.
Combined with the power of BurstDR™ stimulation therapy, the Proclaim™ XR SCS system is our latest advancement in neurostimulation therapy (also called SCS).
Not only does it offer you superior pain relief,** but unlike other SCS systems that require frequent charging sessions to maintain therapy, the Proclaim XR SCS system is recharge free. Meaning, you can get hassle-free pain relief with a battery that lasts up to 10 years at low-dose settings* without ever needing to charge the system.
Adam Hammond is one of the people reaping that benefit.
"I've only had my new stimulator for a few months and am already seeing the benefits of the new way the stimulation is delivered," said the 36-year-old husband and father of two, stricken with chronic pain for a decade following a skydiving accident. "Not only am I experiencing significant and continuous pain relief; I also don't have to charge my stimulator. For the first time since my accident, I can live a more seamless life both at work and at home with my family."
Lessons in Iteration
These findings mark a big improvement for Hammond and the thousands like him who depend on BurstDR stimulation as a treatment for chronic pain management. But it's also a lesson in how we think about innovation — maybe even a reason to rethink it.
In many fields, there's a tendency to conflate innovation with invention. What the BurstDR stimulation study shows is that innovation understandably can be about enhancement, the development of new ways to use things more efficiently, more effectively — or all of the above.
For people using BurstDR stimulation, it means taking control of their health and life.
1 Deer T. Efficacy of Burst Spinal Cord Stimulation Microdosing in a De-Novo Patient. Poster presented at: NAPA Pain 2019.
2 De Ridder D, Vanneste S, Plazier M, Vancamp T. Mimicking the Brain: Evaluation of St. Jude Medical's Prodigy Chronic Pain System with Burst Technology. Expert Review of Medical Devices. 2015:12(2):14-150.
* Up to 10 years of battery longevity at the lowest dose setting: 0.6mA, 500 Ohms, duty cycle 30s on/360s off. NOTE: In neurostimulation therapy, "dose" refers to the delivery of a quantity of energy to tissue. Safety comparisons and specific dose-response curves for each dosage have not been clinically established. Refer to the IFU for additional information. Hassle-free means recharge-free.
** When compared to traditional tonic stimulation
See important safety information for BurstDR stimulation.
Neuromodulation Advancements Offer Hope to People in Pain
The Past, Present and Future of Treating Essential Tremor
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.